CDMRP Reconstructive Transplant Research Program: Technology Development Award

The RTR program challenges the scientific community to design innovative research that will foster new directions for, and address neglected issues in, the field of reconstructive transplantation (RT), specifically vascularized composite allotransplantation (VCA)-focused research, also known as composite tissue allotransplantation. VCA refers to the transplantation of multiple tissues such as muscle, bone, nerve, and skin, as a functional unit (e.g., a hand or face) from a deceased donor to a recipient with a severe injury.

The Technology Development Award is intended to support research critical for the translation of promising preclinical findings into products focused on reconstructive transplantation.

Applicants must address one or more of the Focus Areas:

• Development of ex vivo VCA tissue preservation strategies to extend the time between procurement and transplantation, with a goal of 24 hours

• Graft clinical monitoring - acute and chronic, as applied to VCA

Funding: $1,000,000

Duration: 3 years

Research Authority due date: 12.9.17
Pre application (required) due date: 20.9.17
Full application: 6.12.17